The Fibrosis-Immunity Interface in Corneal Transplantation
The Fibrosis-Immunity Interface in Corneal Transplantation
批准号:
10630301
负责人:
Thomas Dohlman
金额:
$23.87万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-06-30
关键词:
AddressAdvisory CommitteesApoptosisApplications GrantsAreaBasic ScienceCell SurvivalCell physiologyCellsClinicalCoculture TechniquesCorneaDataDevelopmentDinoprostoneEarEffector CellEnvironmentExtracellular MatrixEyeFailureFibrosisFosteringFoundationsFunctional disorderFundingGoalsGraft RejectionHomeostasisImmuneImmunityImmunologyIn VitroInfiltrationInflammationInflammatoryInstitutionInterferon Type IIInvestigationKeratoplastyLaboratoriesLigandsMassachusettsMediatingMentorsMentorshipModelingMyofibroblastOphthalmologyOrgan TransplantationPF4 GenePatientsPlayPreventionPrevention strategyProcessProductionProgram DevelopmentResearchResearch InstituteResearch PersonnelResearch ProposalsResolutionResourcesRoleScientistSolidStructureSystemT cell regulationT-Cell ActivationT-Cell ProliferationT-LymphocyteTNF geneTestingTh1 CellsTissuesTrainingTraining ProgramsTransforming Growth Factor betaTranslatingTransplantationTransplantation ImmunologyTumor Necrosis Factor-BetaUnited States National Institutes of HealthWorkcareercareer developmentcorneal scareffector T cellexperiencegraft failureimmunoregulationin vivoinflammatory milieuinsightinterestisoimmunitymedical schoolsnovelnovel strategiesnovel therapeutic interventionpreventreceptorrepairedresearch and developmentresponseresponse to injurysuccesstherapeutic targettranslational potentialtransplant model
中文摘要
项目总结/摘要
目前的建议是一个全面的五年培训计划,以发展一个学术
他的职业生涯集中在理解T细胞免疫和角膜纤维化之间的关系。
我在移植免疫学和眼科学方面有很强的研究背景
角膜培训,对角膜纤维化有临床兴趣。作为先进的临床和研究角膜
在Mass。眼耳和哈佛医学院,我继续我的工作,在角膜移植
免疫学,证明在角膜移植的T细胞介导的免疫排斥中存在纤维化。
我们的初步数据表明,在角膜移植中,T细胞在促进
肌成纤维细胞形成和纤维化,而肌成纤维细胞又能够调节同种异体反应性T细胞
功能这些数据为我们目前的研究方案奠定了基础,
角膜移植中的纤维化-免疫界面在具体目标1中,我们将定义关键机制
通过效应T细胞促进纤维化,并评估这些机制的调节是否可以预防纤维化,
纤维化和体内移植失败。在具体目标2中,我们将定义关键机制,
肌成纤维细胞抑制效应T细胞以恢复免疫稳态。拟议研究的目标是
研究这些基本机制,并最终开发新的治疗策略,
预防移植物纤维化和抑制器官移植中的T细胞免疫。
Reza Dana博士是世界角膜免疫学专家,长期致力于培养角膜免疫学专业人才。
临床科学家的发展将成为我的主要导师,我还将得到以下方面的支持:
由独立的NIH资助的科学家组成的咨询团队,每个人都有丰富的经验,
指导年轻的研究人员。拟议的研究和职业发展方案将在
Schepens眼科研究所/马萨诸塞州眼耳医院和哈佛医学院,
将能够充分利用这些机构的大量资源。
我致力于作为一名临床科学家的职业生涯,其首要目标是将我的
基础科学研究新的方法来解决病人的未满足的需求。K 08基金
这里详细介绍的建议涉及角膜病理生理学的一个重要和以前未探索的领域
同时也为我提供了成为一个
独立临床科学家
英文摘要
PROJECT SUMMARY/ABSTRACT
The present proposal is a comprehensive five-year training program for the development of an academic
career focused on understanding the relationship between T cell immunity and fibrosis in the cornea.
I have a strong research background in transplantation immunology and sub-specialty ophthalmology
training in cornea, with a clinical interest in corneal fibrosis. As an Advanced Clinical and Research Cornea
Fellow at Mass. Eye and Ear and Harvard Medical School, I have continued my work in corneal transplantation
immunology, demonstrating the presence of fibrosis in T cell-mediated immune rejection of corneal transplants.
Our preliminary data suggest that in corneal transplantation, T cells play a direct role in promoting
myofibroblast formation and fibrosis, and that myofibroblasts are in turn capable of regulating alloreactive T cell
function. This data has laid the foundation for the current research proposal in which we will investigate the
fibrosis-immunity interface in corneal transplantation. In Specific Aim 1 we will define the critical mechanisms
by which effector T cells promote fibrosis and evaluate whether modulation of these mechanisms can prevent
fibrosis and transplant failure in vivo. In Specific Aim 2 we will define the critical mechanisms by which
myofibroblasts suppress effector T cells to restore immune homeostasis. The goal of the proposed research is
to investigate these fundamental mechanisms and ultimately develop novel therapeutic strategies for the
prevention of graft fibrosis and suppression of T cell immunity in organ transplantation.
Dr. Reza Dana, a world expert in corneal immunology with a long track-record of fostering the career
development of clinician-scientists will serve as my primary mentor, and I will additionally have the support of
an advisory team composed of independent NIH-funded scientists, each with extensive experience in
mentoring young researchers. The proposed research and career development programming will take place at
the Schepens Eye Research Institute/Massachusetts Eye and Ear Infirmary and Harvard Medical School, and I
will have full access to the significant resources of these institutions.
I am committed to a career as a clinician-scientist, with the over-arching goal being to translate my
basic science investigations into novel approaches for addressing the unmet needs of patients. The K08 grant
proposal detailed here addresses an important and previously unexplored area of corneal pathophysiology
while simultaneously providing me the mentorship, resources and academic foundation needed to become an
independent clinician-scientist.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.14440/jbm.2021.373
发表时间:
2021
期刊:
Journal of biological methods
影响因子:
--
作者:
[Nakagawa H, Blanco T, Kahale F, Bir Singh R, Dohlman TH, Dana R]
通讯作者:
Dana R
Eye Swelling and Decreased Vision in a Patient With Autism.
自闭症患者的眼睛肿胀和视力下降。
DOI:
10.1097/wno.0000000000001832
发表时间:
2023
期刊:
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
影响因子:
--
作者:
[Xu,Jia, Zhang,YanjiaJason, Gonzalez,Efren, Dohlman,ThomasH, Gaier,EricD]
通讯作者:
Gaier,EricD
The Fibrosis-Immunity Interface in Corneal Transplantation
-
批准号:10038363
-
项目类别:
-
资助金额:$23.87万
-
财政年份:2020
-
负责人:Thomas Dohlman
-
依托单位:
The Fibrosis-Immunity Interface in Corneal Transplantation
-
批准号:10437825
-
项目类别:
-
资助金额:$23.87万
-
财政年份:2020
-
负责人:Thomas Dohlman
-
依托单位:
The Fibrosis-Immunity Interface in Corneal Transplantation
-
批准号:10239075
-
项目类别:
-
资助金额:$23.87万
-
财政年份:2020
-
负责人:Thomas Dohlman
-
依托单位:
海外基金